Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin

Cites (502)

Items 401–502 of 502

1. On a peptidomimetic growth hormone-releasing peptide.
   CYRIL Y. BOWERS · 1994 · The Journal of Clinical Endocrinology & Metabolism
2. Circulating ghrelin concentrations are reduced in healthy offspring of Type 2 diabetic subjects, and are increased in women independent of a family history of Type 2 diabetes
   Torben Østergård, Troels Kjærskov Hansen, B. Nyholm · 2003 · Diabetologia
3. Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express Fos protein following systemic injection of GH-releasing peptide-6
   Suzanne L. Dickson, Odile Viltart, Richard E.J. Dyball, Gareth Leng · 1996 · Journal of Endocrinology
4. Binding sites for growth hormone-releasing peptide
   Huy Ong, Veronique Bodart, Normand McNicoll · 1998 · Growth Hormone & IGF Research
5. L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion
   B. J. Gertz, David G. Sciberras, L. Yogendran, Katherine Christie, KM Bador, David A. Krupa, Johanna Wittreich, Ian James · 1994 · The Journal of Clinical Endocrinology & Metabolism
6. Selective Lack of Growth Hormone (GH) Response to the GH-Releasing Peptide Hexarelin in Patients with GH-Releasing Hormone Receptor Deficiency
   Hiralal Maheshwari · 1999 · The Journal of Clinical Endocrinology & Metabolism
7. Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging
   Ezio Ghigo, Emanuela Arvat, Laura Gianotti · 1996 · European Journal of Endocrinology
8. Cortistatin modulates memory processes in rats
   Manuel Sánchez-Alavez, Margarita Gómez-Chavarı́n, Luz Navarro · 2000 · Brain Research
9. Pretreatment with Growth Hormone-Releasing Peptide-2 Directly Protects against the Diastolic Dysfunction of Myocardial Stunning in an Isolated, Blood-Perfused Rabbit Heart Model1
   Frank Weekers, Eric Van Herck, Jörgen Isgaard · 2000 · Endocrinology
10. Splanchnic Release of Ghrelin in Humans
    Niels Møller, Jonas Nygren, Troels Krarup Hansen, Hans Ørskov, Jan Frystyk, K. Sreekumaran Nair · 2003 · The Journal of Clinical Endocrinology & Metabolism
11. 1H NMR structural analysis of human ghrelin and its six truncated analogs
    Maria Victoria Silva Elipe, Maria A. Bednarek, Ying‐Duo Gao · 2001 · Biopolymers
12. Immunohistochemical localization and biochemical characterization of ghrelin in the brain and stomach of the frog Rana esculenta
    Ludovic Galas, Nicolas Chartrel, Masayasu Kojima · 2002 · The Journal of Comparative Neurology
13. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors
    Katarina Ejeskär, Frida Abel, R M Sjöberg · 2000 · Cytogenetic and Genome Research
14. Adrenocorticotropin and Cortisol Hyperresponsiveness to Hexarelin in Patients with Cushing’s Disease Bearing a Pituitary Microadenoma, But Not in Those with Macroadenoma1
    Emanuela Arvat, Roberta Giordano, Josefina Ramunni · 1998 · The Journal of Clinical Endocrinology & Metabolism
15. Effects of Ghrelin on growth hormone secretion from cultured adenohypophysial cells in pigs
    Tsutomu HASHIZUME, Mami Horiuchi, NAOMI TATE, Sumie NONAKA, Utako MIKAMI, Masayasu Kojima · 2003 · Domestic Animal Endocrinology
16. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man
    Emanuela Arvat, Lidia Di Vito, Laura Gianotti, Josefina Ramunni, M. F. Boghen, Romano Deghenghi, Franco Camanni, Ezio Ghigo · 1997 · Metabolism
17. Endocrine responses to ghrelin in adult patients with isolated childhood‐onset growth hormone deficiency
    Gianluca Aimaretti, Claudia Baffoni, Fabio Broglio, J. A. M. J. L. Janssen, Ginevra Corneli, Romano Deghenghi, Aart Jan van der Lely, Ezio Ghigo, Emanuela Arvat · 2002 · Clinical Endocrinology
18. Growth Hormone-Releasing Hexapeptide Is a Potent Stimulator of Growth Hormone Gene Expression and Release in the Growth Hormone—Releasing Hormone—Deprived Infant Rat
    Vittorio Locatelli, Roberta Grilli, Antonio Torsello · 1994 · Pediatric Research
19. Actions of Leptin on Growth Hormone Secretagogue-Responsive Neurones in the Rat Hypothalamic Arcuate Nucleus Recorded In Vitro
    Y.C. Loraine Tung, Adrian K. Hewson, Suzanne L. Dickson · 2001 · Journal of Neuroendocrinology
20. Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women
    Emanuela Arvat, Laura Gianotti, Fabio Broglio, Barbara Maccagno, Angela Bertagna, Romano Deghenghi, Franco Camanni, Ezio Ghigo · 1997 · European Journal of Endocrinology
21. Age‐related growth hormone‐releasing activity of growth hormone secretagogues in humans
    Emanuela Arvat, Franco Camanni, Ezio Ghigo · 1997 · Acta Paediatrica
22. Consistent GH responses to repeated injections of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585
    Keith M. Fairhall, Anita Mynett, Roy G. Smith, Iain C. A. F. Robinson · 1995 · Journal of Endocrinology
23. Growth Hormone-Independent Cardiotropic Activities of Growth Hormone-Releasing Peptides in Normal Subjects, in Patients with Growth Hormone Deficiency, and in Patients with Idiopathic or Ischemic Dilated Cardiomyopathy
    Fabio Broglio, Andrea Silvio Benso, Maria Rosa Valetto · 2001 · Endocrine
24. Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate
    Marta Calbet, Ana Guadaño‐Ferraz, Avron D. Spier · 1999 · Molecular Brain Research
25. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin
    Paola Cassoni, Giampiero Muccioli, Tiziana Marrocco · 2002 · Journal of Endocrinological Investigation
26. Effects in vitro of New Growth Hormone Releasing Peptide (GHRP‐1) on Growth Hormone Secretion from Ovine Pituitary Cells in Primary Culture
    Danxing Wu, Chen Chen, Jin Zhang · 1994 · Journal of Neuroendocrinology
27. The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus)
    BS Shepherd, SM Eckert, IS Parhar · 2000 · Journal of Endocrinology
28. Growth hormone-inhibiting activity of cortistatin in the rat
    Romano Deghenghi, Roberta Avallone, Antonio Torsello, Giampiero Muccioli, Ezio Ghigo, Vittorio Locatelli · 2001 · Journal of Endocrinological Investigation
29. Cortistatin increase of a potassium conductance in rat locus coeruleus in vitro
    Mark A. Connor, Susan Ingram, MacDonald J. Christie · 1997 · British Journal of Pharmacology
30. Growth Hormone Secretagogues as Diagnostic Tools in Disease States
    Roberto Baldelli, Xose L Otero, Jesús P. Camiña, Oreste Gualillo, Vera M. POPOVIC, Carlos Diéguez, Felipe F. Casanueva · 2001 · Endocrine
31. Cortistatin affects glutamate sensitivity in mouse hypothalamic neurons through activation of somatostatin receptor subtype
    Athena Vassilaki, Christophe Lanneau, P Dournand · 1999 · Neuroscience
32. Hexarelin induced growth hormone release is influenced by exogenous growth hormone
    Ahmed F. Massoud, Peter C. Hindmarsh, C G D Brook · 1995 · Clinical Endocrinology
33. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
    Johan Svensson, Sabrina Lall, Suzanne L. Dickson, B.-Å. Bengtsson, John Rømer, Ian Ahnfelt-Rønne, Claes Ohlsson, J-O Jansson · 2000 · Journal of Endocrinology
34. Effects of Growth Hormone‐Releasing Peptide‐6 on the Nocturnal Secretion of GH, ACTH and Cortisol and on the Sleep EEG in Man: Role of Routes of Administration
    Frieboes, Murck, Antonijevic · 1999 · Journal of Neuroendocrinology
35. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery
    Fabio Broglio, Fabio Guarracino, Andrea Silvio Benso · 2002 · European Journal of Pharmacology
36. Increases in Circulating Insulin-Like Growth Factor I Levels by the Oral Growth Hormone Secretagogue MK-0677 in the Beagle Are Dependent upon Pituitary Mediation1
    Klaus D. Schleim, Thomas M. Jacks, P. Cunningham, William P. Feeney, Easter G. Frazier, GERT W. NIEBAUER, Daowen Zhang, H. Chen, Roy G. Smith, Gerard J. Hickey · 1999 · Endocrinology
37. Small Peptides as Potent Releasers of Growth Hormone
    Romano Deghenghi, F. Boutignon, M. Luoni · 1995 · Journal of Pediatric Endocrinology and Metabolism
38. Melatonin and the Wintering Strategy of the Tundra Vole, Microtus oeconomus
    Anne‐Mari Mustonen, Petteri Nieminen, Heikki Hyvärinen · 2002 · ZOOLOGICAL SCIENCE
39. Interactive Regulation of Postmenopausal Growth Hormone Insulin-Like Growth Factor Axis by Estrogen and Growth Hormone-Releasing Peptide-2
    Johannes D. Veldhuis, William S. Evans, Cyril Y. Bowers, Stacey M. Anderson · 2001 · Endocrine
40. Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization
    Richard L. Lieber, Thomas M. Jacks, Randall L. Mohler et al. · 1997 · Journal of Orthopaedic Research®
41. Identification of Peptide Ligand-binding Domains within the Human Motilin Receptor Using Photoaffinity Labeling
    Bernard J. Coulie, Bunzo Matsuura, Maoqing Dong · 2001 · Journal of Biological Chemistry
42. The Nonpeptide Growth Hormone Secretagogue, MK‐0677, Activates Hypothalamic Arcuate Nucleus Neurons in vivo
    Bailey, Smith, Gareth Leng · 1998 · Journal of Neuroendocrinology
43. Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine.
    Ching-Hsin Chang, Eric L. Rickes, Frank Marsilio · 1995 · Endocrinology
44. Insulin Therapy in Type 2 Diabetes
    R. Keith Campbell, John Raymond White · 2002 · Journal of the American Pharmaceutical Association (1996)
45. Maintenance of a Normal Meal-induced Decrease in Plasma Ghrelin Levels in Children with Prader-Willi Syndrome
    Carla Bizzarri, Antonello Emilio Rigamonti, Germana Giannone, R Berardinelli, Silvano Gabriele Cella, Marco Cappa, Eugenio E. Müller · 2004 · Hormone and Metabolic Research
46. Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation
    Rodrigo Moreno‐Reyes, Myriam Kerkhofs, Mireille L’Hermite‐Balériaux, Michael O. Thorner, Eve Van Cauter, Georges Copinschi · 1998 · American Journal of Physiology-Endocrinology and Metabolism
47. Effects of Growth Hormone Secretagogues on Prolactin Release in Anesthetized Dwarf (dw/dw) Rats*
    Danielle F. Carmignac, Pamela A. Bennett, Iain C. A. F. Robinson · 1998 · Endocrinology
48. Effects of Growth Hormone‐Releasing Peptide‐2 (GHRP‐2) on Membrane Ca2+ Permeability in Cultured Ovine Somatotrophs
    Chen Chen, Iain James Clarke · 1995 · Journal of Neuroendocrinology
49. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans
    Fabio Broglio, Cristina Gottero, Andrea Silvio Benso, Flavia Prodam, Felipe F. Casanueva, Carlos Diéguez, Aart Jan van der Lely, Romano Deghenghi, Emanuela Arvat, Ezio Ghigo · 2003 · Clinical Endocrinology
50. Growth Hormone‐Releasing Hormone and Growth Hormone‐Releasing Peptide as Potential Therapeutic Modalities
    Michael O. Thorner, Michaela L. Vance, Alan David Rogol, Robert M. Blizzard, Johannes D. Veldhuis, Eve Van Cauter, Georges Copinschi, C. Y. Bowers · 1990 · Acta Paediatrica
51. Electrical Stimulation of the Rat Periventricular Nucleus Influences the Activity of Hypothalamic Arcuate Neurones
    Suzanne L. Dickson, Gareth Leng, Iain C.A.F. Robinson · 1994 · Journal of Neuroendocrinology
52. GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans.
    CYRIL Y. BOWERS, Ramona Granda-Ayala · 1996 · PubMed
53. Motilin and motilin receptors: characterization and functional significance.
    Inge Depoortere · 2001 · PubMed
54. Growth Hormone Secretagogues in Critical Illness
    Greet Van den Berghe · 1999 · Hormone Research in Paediatrics
55. Diagnostic studies with intravenous and intranasal growth hormone- releasing peptide-2 in children of short stature
    C. Pihoker · 1995 · The Journal of Clinical Endocrinology & Metabolism
56. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)
    Zvi Laron, Jenny Frenkel, Lrit Gil‐Ad, Beatrice Klinger, Ernesto Lubin, Patrick Wüthrich, F. Boutignon, Vincent Lengerts, Romano Deghenghi · 1994 · Clinical Endocrinology
57. GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers
    Anatoly Nikolaevich Tiulpakov, C G D Brook, P. J. Pringie · 1995 · Clinical Endocrinology
58. Somatostatin Octapeptides (Lanreotide, Octreotide, Vapreotide, and Their Analogs) Share the Growth Hormone–Releasing Peptide Receptor in the Human Pituitary Gland
    Romano Deghenghi, Mauro Giulio Papotti, Ezio Ghigo · 2001 · Endocrine
59. GH-Independent Cardiotropic Activities of Hexarelin in Patients with Severe Left Ventricular Dysfunction Due to Dilated and Ischemic Cardiomyopathy
    Massimo Imazio, Marco Bobbio, Fabio Broglio · 2002 · European Journal of Heart Failure
60. Effect of Intravenous or Intracerebroventricular Injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH 2 on GH Release in Conscious, Freely Moving Male Rats
    Hiroji Yagi, Hidesuke Kaji, Michiaki Sato · 2008 · Neuroendocrinology
61. Adrenocorticotropin and Cortisol Hyperresponsiveness to Hexarelin in Patients with Cushing's Disease Bearing a Pituitary Microadenoma, But Not in Those with Macroadenoma
    Emanuela Arvat · 1998 · The Journal of Clinical Endocrinology & Metabolism
62. Molecular Biology of the Receptors for Somatostatin and Cortistatin
    Hans‐Jürgen Kreienkamp · 1999 · Results and problems in cell differentiation
63. Responses of seasonally anovulatory mares to daily administration of thyrotropin-releasing hormone and(or) gonadotropin-releasing hormone analog
    L. R. Gentry, Donald L. Thompson, A. M. Stelzer · 2002 · Journal of Animal Science
64. Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short stature
    Anatoly N. Tuilpakov, А. А. Булатов, V.A. Peterkova · 1995 · Metabolism
65. Growth hormone secretagogues as corticotrophin-releasing factors
    Ezio Ghigo, Emanuela Arvat, Franco Camanni · 1998 · Growth Hormone & IGF Research
66. Inhibition of L-692,429-stimulated rat growth hormone release by a weak substance P antagonist: L-756,867
    K Cheng, Lijuan Wei, L-Y Chaung · 1997 · Journal of Endocrinology
67. Determination of a novel growth hormone secretagogue (MK-677) in human plasma at picogram levels by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry
    Marvin L. Constanzer, C.M. Chavez-Eng, Bogdan K. Matuszewski · 1997 · Journal of Chromatography B Biomedical Sciences and Applications
68. Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro
    Jen Yu Wei, Yu Hua Wang · 2000 · American Journal of Physiology-Endocrinology and Metabolism
69. Use of Growth Hormone and Growth Hormone Secretagogues in Aging: Help or Harm
    Omid Khorram · 2001 · Clinical Obstetrics & Gynecology
70. Growth hormone secretagogues:mechanism of action and use in aging
    Vivian L. Fuh, Mark A. Bach · 1998 · Growth Hormone & IGF Research
71. The cortical neuropeptide, cortistatin-14, impairs post-training memory processing
    James F. Flood, Kayoko Uezu, John Edward Morley · 1997 · Brain Research
72. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man
    Emanuela Arvat, Laura Gianotti, Josefina Ramunni · 1996 · Journal of Endocrinological Investigation
73. Extensive DNA Fragmentation in Oxyphilic Cell Lesions of the Thyroid
    Marco Volante, Mauro Papott, Patrizia Gugliotta · 2001 · Journal of Histochemistry & Cytochemistry
74. Motilin-related peptide and ghrelin: Lessons from molecular techniques, peptide chemistry, and receptor biology
    Juan P. del Rincon, Michael O. Thorner, Bruce D. Gaylinn · 2001 · Gastroenterology
75. Induction of c-fos mRNA in the arcuate nucleus of normal and mutant growth hormone-deficient mice by a synthetic non-peptidyl growth hormone secretagogue
    D.J.S. Sirinathsinghji, H. Y. Chen, Ruth Hopkins · 1995 · Neuroreport
76. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly
    FM van der Toorn, J. A. M. J. L. Janssen, WW de Herder, Fabio Broglio, Ezio Ghigo, AJ van der Lely · 2002 · European Journal of Endocrinology
77. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
    Vito De Gennaro Colonna, Giuseppe Rossoni, Micaela Maria Bernareggi · 1997 · PubMed
78. Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal
    Michael Ankersen, Karin Kramer Nielsen, Thomas Kruse Hansen · 2000 · European Journal of Medicinal Chemistry
79. Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle
    Ivano Bedendi, Maria Pia Gallo, Daniela Malan · 2001 · Life Sciences
80. Administration of a Nonpeptidyl Growth Hormone Secretagogue, L-163,255, Changes Somatostatin Pattern, But Has No Effect on Patterns of Growth Hormone-Releasing Factor in the Hypophyseal-Portal Circulation of the Conscious Pig
    Jennifer E. Drisko, Terry D. Faidley, D. Zhang, T. J. McDonald, Susan Nicolich, D. F. Hora, P. Cunningham, C. Li, Eric L. Rickes, Lesley Ann McNamara et al. · 1999 · Proceedings of The Society for Experimental Biology and Medicine
81. Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement
    Giuseppe Murdolo, Paola Lucidi, Chiara Di Loreto, Natascia Parlanti, A. De Cicco, Carmine Giuseppe Fanelli, Gabriele Perriello, Debora Mughetti, Roberto Pippi, Annalisa Brozzetti et al. · 2003 · Journal of Endocrinological Investigation
82. Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride
    Sophie Kennedy, Donald L. Thompson, H. E. Pruett · 2002 · Journal of Animal Science
83. Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a)1
    Johan Svensson, John‐Olov Jansson, Malin Ottosson, Gudmundur Johannsson, Marja‐Riitta Taskinen, Olov Wiklund, B.-Å. Bengtsson · 1999 · The Journal of Clinical Endocrinology & Metabolism
84. Effect of d-Ala-d-βNal-Ala-Trp-d-Phe-Lys-NH2 (KP-102) on GH secretion in urethan-anesthetized rats
    Hideo Sawada, Hitoshi Sugihara, Hiroyuki Onose · 1994 · Regulatory Peptides
85. Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum
    Marie Roumi, Elizabeth C. Kwong, Romano Deghenghi · 2001 · Peptides
86. Growth Hormone/Insulin-Like Growth Factor-1 Response to Acute and Chronic Growth Hormone-Releasing Peptide-2, Growth Hormone-Releasing Hormone 1-44NH and in Combination in Older Men and Women with Decreased Growth Hormone Secretion
    C. Y. Bowers, Ramona Granda-Ayala · 2001 · Endocrine
87. Effects of Growth Hormone Releasing Peptides on Stimulated Growth Hormone Secretion in Old Rats
    Richard F. Walker, SeiWon Yang, Ryuji Masuda · 1994 · Springer eBooks
88. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity
    Ahmed F. Massoud, Peter C. Hindmarsh, David Richard Matthews · 1996 · Clinical Endocrinology
89. Growth hormone secretagogues: recent advances and applications
    Michael Ankersen, Thomas K. Hansen, Ian Ahnfelt-Rønne · 1999 · Drug Discovery Today
90. Physiology and possible pathology of growth hormone secretagogues.
    A Peñalva, Roberto Baldelli, J P Camiña · 2001 · PubMed
91. GH responsiveness to repeated GHRH or hexarelin administration in normal adults
    Alessandro Sartório, Antonio Conti, S. Ferrero · 1995 · Journal of Endocrinological Investigation
92. Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin
    Thomas K. Hansen, Michael Ankersen, Kirsten Raun · 2001 · Bioorganic & Medicinal Chemistry Letters
93. Identification of motilin-related peptide
    Bernard J. Coulie, Laurence J. Miller · 2001 · Gastroenterology
94. New growth hormone secretagogues: C-terminal modified sulfonamide-Analogues of NN703
    Bernd Peschke, Birgit Sehested Hansen · 1999 · Bioorganic & Medicinal Chemistry Letters
95. Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a)
    Johan Svensson · 1999 · The Journal of Clinical Endocrinology & Metabolism
96. Growth hormone secretagogues in children with altered growth
    B B Bercu, RF Walker · 1997 · Acta Paediatrica
97. Regulation and Clinical Assessment of Growth Hormone Secretion
    Allen W. Root, Frank Diamond · 2000 · Endocrine
98. Hexarelin, But Not Growth Hormone, Protects Heart from Damage Induced In Vitro by Calcium Deprivation Replenishment
    Antonio Torsello, Giuseppe Rossoni, Vittorio Locatelli · 2001 · Endocrine
99. Feast or Famine - Are GLP-1 and Ghrelin Secretion Intertwined?
    Christian Djurhuus, Thomas K. Hansen, Jens Juul Holst · 2002 · Hormone and Metabolic Research
100. Peptides, sleep and cortistatin.
     Luı́s de Lecea, J. Gregor Sutcliffe · 1996 · PubMed
101. Theodore R. Woodward Award. Age-related decline in growth hormone secretion: clinical significance and potential reversibility.
     M O Thorner · 1997 · PubMed
102. Growth hormone secretagogues astherapeutic agents
     Johan Svensson · 1999 · Growth Hormone & IGF Research